Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | ALPL | P05186 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | ILK | Q13418 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1806510 | 0.88 | PDE4D (0.35) | PDE4DCA12ALPLCA9HCAR3 | |
| SCHEMBL1807105 | 0.84 | PRKCE (0.39) | PDE4DALDH1A1CA12ALPLCA9 | |
| SCHEMBL1805098 | 0.81 | PDE4D (0.33) | PDE4DCA12ALPLCA9HCAR2 | |
| SCHEMBL1805134 | 0.80 | PDE4D (0.34) | PDE4D | |
| SCHEMBL1809879 | 0.80 | XDH (0.34) | PDE4DALDH1A1CA12ALPLCA9 | |
| SCHEMBL1803881 | 0.79 | HTR2A (0.34) | ALDH1A1 | |
| SCHEMBL1804789 | 0.72 | PDE4D (0.46) | PDE4DALDH1A1CA12CA9 | |
| SCHEMBL1806149 | 0.66 | HCAR2 (0.42) | CA12ALPLCA9HCAR2 | |
| SCHEMBL12181094 | 0.66 | RXRA (0.44) | ALDH1A1CA12ALPLCA9 | |
| SCHEMBL27685454 | 0.64 | PTGS1 (0.40) | ALDH1A1ALOX15HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2501704-A1 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS | Eli Lilly and Company (US) | 2012-09-26 | — | — | EP | disclosed |
| WO-2011060217-A1 | SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |